Subject: Tanzania | Vaccine | Barriers | veterinary(all) | Schools | Immunology and Microbiology(all) | Human papillomavirus | Infectious Diseases | Molecular Medicine | Article | Acceptability | Public Health, Environmental and Occupational Health
Background As human papillomavirus (HPV) vaccines become available in developing countries, acceptability studies can help to better understand potential barriers and facilitators of HPV vaccination and guide immunisation programs. Methods Prior to a cluster-randomised ... View more
 International Agency for Research on Cancer. Estimated cervical cancer mortality worldwide in 2008. Available at http://globocan.iarc.fr/ factsheets/cancers/cervix.asp [last accessed: June 2011].
 WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers in Tanzania. Summary Report 2010. Available at http://www.who.int/hpvcentre [last accessed: January 2011].
 Harper DM, Franco EL, Wheeler C, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-55.
 Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 viruslike particle vaccine through 5 years follow-up. Br J Cancer 2006;6:1459-66.
 De Carvalho N, Teixeira J, Roteli-Martins CM, Naud P, De Borba P, Zahaf T, et al. Sustained efficacy and immunogenicity of the HPV 16/18 ASO4-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine 2010;28:6247-55.
 World Health Organization. Human papillomavirus vaccines WHO position paper. Wkly Epidemiol Rec 2009;15(84):117-32.
 Stokley S, Cohn A, Jain N, McCauley MM. Compliance with recommendations and opportunities for vaccination at ages 11-12 years: evaluation of the 2009 National Immunization Survey-Teen. Arch Pediatr Adolesc Med 2011;165(9):813-8.
 Department of Health & Health Protection Agency. Annual HPV vaccine coverage in England in 2009/2010. Available at http://www.dh.gov.uk/prod consum dh/groups/dh digitalassets/documents/digitalasset/dh 123826.pdf [last accessed: September 2011].
 Dorell C, Stokley S, Yankey D, Liang J, Markowitz L. National and state vaccinattion coverage among adolescents aged 13 through 17 years, United States, 2010. Morb Mortal Wkly Rep 2011;60(33):1117-23.
 European Cervical Cancer Association. HPV vaccination across Europe. Available at http://www.ecca.info/fileadmin/user upload/ HPV Vaccination/ECCA HPV Vaccination April 2009.pdf [last accessed: September 2011].